XIST has also been proposed to act as a tumor suppressor in breast cancer by regulating phosphorylated AKT [26], and as an oncogene in non-small cell lung cancer by downregulating the tumor suppressor KLF2 [27]. This evidence concerns the gene AKT1 and breast carcinoma.